Oligodendroglioma
This graph shows the total number of publications written about "Oligodendroglioma" by people in the URMC Research Network by year, and whether "Oligodendroglioma" was a major or minor topic of these publication.
Below are the most recent publications written about "Oligodendroglioma" by people in Profiles.
-
Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010 Dec 14; 18(6):669-82.
-
Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, Rosenblum M, Patel SC, Mikkelsen T. Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors. J Neurooncol. 2011 Apr; 102(2):287-93.
-
Shah MN, Leonard JR, Perry A. Rosette-forming glioneuronal tumors of the posterior fossa. J Neurosurg Pediatr. 2010 Jan; 5(1):98-103.
-
Mohile NA, Forsyth P, Stewart D, Raizer JJ, Paleologos N, Kewalramani T, Louis DN, Cairncross JG, Abrey LE. A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis. J Neurooncol. 2008 Sep; 89(2):187-93.
-
Noble M, Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci. 2004 Mar; 27(3):148-54.
-
De Witte O, Levivier M, Violon P, Salmon I, Damhaut P, Wikler D, Hildebrand J, Brotchi J, Goldman S. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery. 1996 Sep; 39(3):470-6; discussion 476-7.
-
Venter DJ, Stratton MR, Noble MD. Molecular genetic study showing that the IN/157 'oligodendroglioma' cell line has been contaminated by rhabdomyosarcoma (RD) cells. Neuropathol Appl Neurobiol. 1992 Apr; 18(2):159-69.
-
Yung WK, Prados M, Levin VA, Fetell MR, Bennett J, Mahaley MS, Salcman M, Etcubanas E. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. J Clin Oncol. 1991 Nov; 9(11):1945-9.
-
Kennedy PG, Watkins BA, Thomas DG, Noble MD. Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol Appl Neurobiol. 1987 Sep-Oct; 13(5):327-47.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
